Vishnu S Potluri, MD MPH

faculty photo
Assistant Professor of Medicine (Renal-Electrolyte and Hypertension) at the Hospital of the University of Pennsylvania
Senior Fellow, Leonard Davis Institute of Health Economics
Senior Scholar, Center for Clinical Epidemiology and Biostatistics
Department: Medicine

Contact information
3400 Spruce Street
One Founders, Renal Division
Philadelphia, PA 19104
Education:
MD (Medicine)
PSI Medical College, 2010.
MPH (Public Health and Epidemiology)
University of Pennsylvania, 2013.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Shah S, Potluri VS, Bloom RD, Lim MA.: The Status of Kidney Transplant Fellowship in the United States: A Survey of Program Directors. Am J Kidney Dis Sep 2023.

Yamauchi J, Azhar A, Hall IE, Bhalla A, Potluri VS, Tanriover B, Gupta G, Imlay H, Truax C, Balaraman V, Raghavan D, Zimmerman M, Campsen J, Rofaiel G, Baker T, Molnar MZ.: Comparison of Short-Term Outcomes in Kidney Transplant Recipients from SARS-CoV-2-Infected versus Noninfected Deceased Donors. Clin J Am Soc Nephrol Aug 2023.

Reese PP, Diamond JM, Goldberg DS, Potluri V, Prenner S, Blumberg EA, Van Deerlin VM, Reddy KR, Mentch H, Hasz R, Woodards A, Gentile C, Smith J, Bermudez C, Crespo MM.: The SHELTER Trial of Transplanting Hepatitis C Virus-Infected Lungs Into Uninfected Recipients. Transplant Direct 9: e1504, Jun 2023.

Potluri V, Naqvi F, Goldberg DS, Shah M, Loupy A, Abt P, Blumberg E, Trofe-Clark J, Bloom R, Sawinski D, Chattergoon M, Segev DL, Bair-Marcantoni N, Durand CM, Reddy R, Levine M, Brown N, Mapchan S, Aubert O, Desai N, Reese PP.: Longer-Term Clinical Outcomes From the THINKER and EXPANDER Trials of Transplantation of HCV-RNA+ Donor Kidneys Into Hepatitis C Virus-Negative Recipients. Kidney Int Rep 8: 1460-1463, Apr 2023.

Potluri V, Kulkarni S.: Time to reconsider the role of donor hepatitis C status in the Kidney Donor Risk Index. Am J Transplant 2023.

Schaubel DE, Tran AH, Abt PL, Potluri VS, Goldberg DS, Reese PP.: Five-Year Allograft Survival for Recipients of Kidney Transplants From Hepatitis C Virus Infected vs Uninfected Deceased Donors in the Direct-Acting Antiviral Therapy Era. JAMA 328: 1102-1104, Sep 2022.

Saine ME, Schnellinger EM, Liu M, Diamond JM, Crespo MM, Prenner S, Potluri V, Bermudez C, Mentch H, Moore M, Besharatian B, Goldberg DS, Barg FK, Reese PP.: Decision-making Among Hepatitis C Virus-negative Transplant Candidates Offered Organs from Donors with HCV Infection. Transplant Direct 8: e1341, Jul 2022.

V. Potluri, P. Reese, S. Prenner, H. Mentch, D. Goldberg, T. Claridge, J. Smith, C. Gentile, V. Van Deerlin, R. Reddy, T. Fallah, C. Bermudez, M. Crespo, J. Diamond: Oral Presentation: The SHELTER Trial Of Transplanting Donor Hepatitis C Virus RNA+ Lungs Into Uninfected Recipients. American Transplant Congress June 2022.

Molnar MZ, Potluri VS, Schaubel DE, Sise ME, Concepcion BP, Forbes RC, Blumberg E, Bloom RD, Shaffer D, Chung RT, Strohbehn IA, Elias N, Azhar A, Shah M, Sawinski D, Binari LA, Talwar M, Balaraman V, Bhalla A, Eason JD, Besharatian B, Trofe-Clark J, Goldberg DS, Reese PP: Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation. American Journal of Transplantation 22(2): 599-609, Feb 2022.

Potluri VS, Bloom RD: Induction Therapy in Immunologically Well-Matched Recipients: Less May Be More. Clinical Journal of the American Society of Nephrology 17: 173-175, February 2022.

back to top
Last updated: 09/25/2023
The Trustees of the University of Pennsylvania